CTR9 and neoplasm: In contrast, depletion of CTR9 caused an increase in the number of (CD3-positive) T-cells, and of cDC1 cells, which are dendritic cells that stimulate T-cell responses against tumors and locally present tumor antigens to re-stimulate T-cells (Fig. 6b)52.